Vivani Medical Future Growth

Future criteria checks 0/6

Vivani Medical's earnings are forecast to decline at 10.3% per annum. EPS is expected to decline by 5.8% per annum.

Key information

-10.3%

Earnings growth rate

-5.8%

EPS growth rate

Medical Equipment earnings growth	17.1%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	Low
Last updated	13 Nov 2024

Recent future growth updates

No updates

Recent updates

Companies Like Vivani Medical (NASDAQ:VANI) Are In A Position To Invest In Growth

Apr 07

We Think Vivani Medical (NASDAQ:VANI) Can Afford To Drive Business Growth

Dec 06

Earnings and Revenue Growth Forecasts

NasdaqCM:VANI - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	N/A	-32	N/A	N/A	1
12/31/2025	N/A	-26	N/A	-22	2
12/31/2024	N/A	-24	N/A	-19	2
9/30/2024	N/A	-23	-19	-18	N/A
6/30/2024	N/A	-24	-22	-20	N/A
3/31/2024	N/A	-25	-22	-21	N/A
12/31/2023	N/A	-26	-25	-24	N/A
9/30/2023	N/A	-27	-26	-25	N/A
6/30/2023	N/A	-19	-25	-25	N/A
3/31/2023	N/A	-16	-23	-23	N/A
12/31/2022	N/A	-14	-19	-19	N/A
9/30/2022	N/A	-10	-17	-17	N/A
6/30/2022	N/A	-15	-13	-13	N/A
3/31/2022	N/A	-14	-12	-12	N/A
12/31/2021	N/A	-13	-12	-11	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VANI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VANI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VANI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if VANI's revenue is forecast to grow faster than the US market.

High Growth Revenue: VANI is forecast to have no revenue next year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VANI's Return on Equity is forecast to be high in 3 years time

Vivani Medical Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical, Inc. Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

We Think Vivani Medical (NASDAQ:VANI) Needs To Drive Business Growth Carefully

Vivani Medical, Inc. Provides Update on Clinical Development Plans for Miniature, Long-Term, GLP-1 Obesity Implant Program, NPM-115

Vivani Medical, Inc. Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical, Inc. Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical, Inc., Annual General Meeting, Jun 27, 2024

Vivani Medical, Inc. has filed a Follow-on Equity Offering in the amount of $75 million.

New minor risk - Market cap size

Director notifies of intention to sell stock

New major risk - Revenue and earnings growth

Vivani Medical, Inc. Appoints Daniel Bradbury to Its Board of Directors

Vivani Medical, Inc. has filed a Follow-on Equity Offering in the amount of $15 million.

New major risk - Share price stability

Vivani Medical, Inc. Receives Written Notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Minimum Bid Price Requirement

Vivani Medical, Inc. Receives Written Notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Minimum Bid Price Requirement

Independent Chairman of the Board recently bought US$135k worth of stock

Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?

New major risk - Financial position

Independent Chairman of the Board recently bought US$103k worth of stock

Independent Chairman of the Board recently bought US$90k worth of stock

Independent Chairman of the Board recently bought US$97k worth of stock

Independent Chairman of the Board recently bought US$50k worth of stock

Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation

Director recently bought US$1.8m worth of stock

Companies Like Vivani Medical (NASDAQ:VANI) Are In A Position To Invest In Growth

We Think Vivani Medical (NASDAQ:VANI) Can Afford To Drive Business Growth

No independent directors

Vivani Medical, Inc.(NasdaqCM:VANI) dropped from S&P Global BMI Index

Vivani Medical, Inc. Announces Chief Executive Officer Changes

No independent directors

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies